Diversified drugs and chemicals group Merck KGaA is ready to pursue a takeover worth billions to boost its medicines unit even after making an offer for AZ Electronic Materials, its chief executive told a German newspaper. “We can easily invest a high single-digit billion amount, without endangering our good rating,” CEO Karl-Ludwig Kley was quoted as saying by daily Handelsblatt. Standard & Poor’s has a long-term issuer rating ‘A’ with a stable outlook on Merck.
Help employers find you! Check out all the jobs and post your resume.
